Using bleomycin-induced models of dermal and pulmonary fibrosis, CCL24 knockout prevented dermal thickening, reduced collagen content, and reduced white blood cell and mononuclear cell counts in bronchoalveolar lavage (BAL) fluid [121]. This evidence concerns the gene CCL24 and pulmonary fibrosis.